Pyomyositis Market Size & Share, by Type (Primary, Secondary), End User (Hospitals, Clinics, Pharmaceutical Companies) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5402
  • Published Date: Nov 27, 2023
  • Report Format: PDF, PPT

Companies Dominating the Pyomyositis Landscape

top-features-companies
    • Pfizer Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Merck & Co., Inc.
    • GlaxoSmithKline (GSK)
    • Novartis International AG
    • Sanofi S.A.
    • Johnson & Johnson
    • Roche Holding AG
    • AstraZeneca PLC
    • Gilead Sciences, Inc.
    • Teva Pharmaceutical Industries Ltd.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Merck acquired VXRT Inc., a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer, for USD 3.2 billion. The acquisition strengthened Merck's vaccine pipeline and added new vaccine candidates for COVID-19 and other infectious diseases.
  • Merck acquired Peloton Therapeutics, Inc., a clinical-stage biotechnology company developing novel therapies for the treatment of cancer, for USD 1.1 billion. The acquisition added several new cancer therapy candidates to Merck's pipeline, including PT-101, a small molecule inhibitor of DDR1, and PT-102, a small molecule inhibitor of MTAP.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5402
  • Published Date: Nov 27, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand from healthcare sector is the major factor driving the market growth.

The market size of pyomyositis is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2024-2036.

The major players in the market Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline (GSK), Novartis International AG, Sanofi S.A., Johnson & Johnson, and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying